Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson’s Disease Patients-Reference-Cited by-同舟云学术

Enzyme Immunoassay-Based Platform for Accurate Detection of Serum Pathological α-Synuclein in Parkinson’s Disease Patients

Published:2020-11-16 Issue:24 Volume:11 Page:4179-4190
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Schlichtmann Benjamin W.¹²^ORCID,Kondru Naveen³,Hepker Monica M.³,Kanthasamy Anumantha G.³²,Anantharam Vellareddy⁴²,John Manohar⁵²,Ban Bhupal⁶,Mallapragada Surya K.¹²^ORCID,Narasimhan Balaji¹²^ORCID

Affiliation:

1. Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, United States

2. Nanovaccine Institute, Ames, Iowa 50011, United States

3. Department of Biomedical Sciences, Iowa State University, Ames, Iowa 50011, United States

4. PK Biosciences Corporation, Ames, Iowa 50011, United States

5. PathoVacs, Incorporated, Ames, Iowa 50011, United States

6. Indiana Biosciences Research Institute (IBRI), Indianapolis, Indiana 46202, United States

Funder

National Institute of Environmental Health Sciences

National Institute of Neurological Disorders and Stroke

Iowa State University

Nanovaccine Institute, Iowa State University

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.0c00461

Reference47 articles.

1. Epidemiology of Parkinson's disease

2. Yang, G., Schmiel, L., Zhou, M., Cintina, I., Spencer, D., and Hogan, P. Economic Burden and Future Impact of Parkinson’s Disease—Final Report, https://www.michaeljfox.org/sites/default/files/media/document/2019Parkinson%27sEconomicBurdenStudy-FINAL.pdf (accessed 2020-06-01).

3. Animal models of α-synucleinopathy for Parkinson disease drug development

4. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

5. Detection of Parkinson’s Disease through the Peptoid Recognizing α-Synuclein in Serum

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single Particle Colorimetric Acid Phosphatase Activity Assay with CeO2-modified Gold Nanoparticles;Chemical Research in Chinese Universities;2024-03-12

2. An innovative transportable immune device for the recognition of α-synuclein using KCC-1-nPr-CS₂ modified silver nano-ink: integration of pen-on-paper technology with biosensing toward early-stage diagnosis of Parkinson's disease;RSC Advances;2024

3. Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression;Biomolecules;2023-07-31

4. Rational design of nonlinear hybridization immunosensor chain reactions for simultaneous ultrasensitive detection of two tumor marker proteins;Analytical Methods;2023

5. Enhanced Plasmonic Biosensor Utilizing Paired Antibody and Label-Free Fe3O4 Nanoparticles for Highly Sensitive and Selective Detection of Parkinson’s α-Synuclein in Serum;Biosensors;2021-10-18